After a localized inflammatory process with the secretion of IL-1 cytokines from, e.g., macrophages and neutrophils, CRC tumor cells can create a positive feedback loop, promoting the expression of more pro-inflammatory cytokines that stimulate cancer-cell proliferation and drug resistance [36]. This evidence concerns the gene IL1B and cancer.